New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis.
Bacillus Calmette-Guérin
biomarker
bladder cancer
immunotherapy
microbiome
non-muscle-invasive bladder cancer
omics
prognostic factor
Journal
Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988
Informations de publication
Date de publication:
2020
2020
Historique:
received:
14
02
2020
accepted:
09
06
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
28
8
2020
Statut:
epublish
Résumé
About 70% of bladder cancers (BCs) are diagnosed as non-muscle-invasive BCs (NMIBCs), while the remaining are muscle-invasive BCs (MIBCs). The European Association of Urology (EAU) guidelines stratify NMIBCs into low, intermediate, and high risk for treatment options. Low-risk NMIBCs undergo only the transurethral resection of the bladder (TURB), whereas for intermediate-risk and high-risk NMIBCs, the transurethral resection of the bladder (TURB) with or without
Identifiants
pubmed: 32850635
doi: 10.3389/fchem.2020.00600
pmc: PMC7413024
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
600Informations de copyright
Copyright © 2020 Pane, Mirabelli, Coppola, Illiano, Salvatore and Franzese.
Références
Eur Urol Oncol. 2019 May 14;:
pubmed: 31411976
Appl Microbiol Biotechnol. 2015 May;99(9):3741-54
pubmed: 25794874
Curr Opin Microbiol. 2017 Jun;37:95-102
pubmed: 28623720
J Med Chem. 2019 Jan 24;62(2):420-444
pubmed: 30035545
Sci Rep. 2018 Aug 14;8(1):12157
pubmed: 30108246
Front Oncol. 2018 Aug 23;8:315
pubmed: 30191140
Int J Mol Sci. 2020 Jan 31;21(3):
pubmed: 32023888
BJU Int. 2019 Jul;124(1):7-8
pubmed: 30663202
Cancer Chemother Pharmacol. 2018 Apr;81(4):629-645
pubmed: 29368051
Int J Urol. 2017 May;24(5):342-351
pubmed: 28326624
Expert Opin Biol Ther. 2016;16(2):273-83
pubmed: 26865049
Eur Urol. 2019 Nov;76(5):639-657
pubmed: 31443960
Front Cell Infect Microbiol. 2019 May 01;9:133
pubmed: 31119104
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Eur Urol Focus. 2018 Jul;4(4):503-505
pubmed: 30017900
Lancet. 2016 Dec 3;388(10061):2796-2810
pubmed: 27345655
World J Urol. 2018 Nov;36(11):1727-1740
pubmed: 29855698
Int J Mol Sci. 2019 Nov 29;20(23):
pubmed: 31795520
Int Immunol. 2007 Jul;19(7):813-24
pubmed: 17606980
Expert Opin Investig Drugs. 2019 Sep;28(9):757-770
pubmed: 31412742
Int J Mol Sci. 2017 Apr 12;18(4):
pubmed: 28417933
Eur J Cancer. 2019 Feb;108:111-119
pubmed: 30654296
Bioinformatics. 2016 Sep 1;32(17):2618-25
pubmed: 27197815
Cancers (Basel). 2020 Feb 24;12(2):
pubmed: 32102334
Curr Opin Urol. 2020 May;30(3):365-369
pubmed: 32141939
Sci Rep. 2020 Jan 14;10(1):281
pubmed: 31937798
Urol Clin North Am. 2020 Feb;47(1):111-118
pubmed: 31757294
Expert Opin Pharmacother. 2019 Aug;20(11):1387-1396
pubmed: 31081702
Ther Adv Urol. 2014 Oct;6(5):181-91
pubmed: 25276228
Microb Cell Fact. 2019 Mar 6;18(1):44
pubmed: 30841891
J Transl Med. 2019 May 22;17(1):172
pubmed: 31118074
Nat Rev Urol. 2019 Feb;16(2):73-74
pubmed: 30510275
J Clin Microbiol. 2010 Jun;48(6):2110-5
pubmed: 20392910
Biochem Biophys Res Commun. 2019 Jan 29;509(1):167-174
pubmed: 30579607
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Am J Clin Exp Urol. 2014 Apr 15;2(1):57-61
pubmed: 25126590
Am J Hum Genet. 2015 May 7;96(5):797-807
pubmed: 25957468
Eur Urol Focus. 2020 May 15;6(3):479-489
pubmed: 30470647
J Glob Infect Dis. 2018 Oct-Dec;10(4):196-200
pubmed: 30581260
N Biotechnol. 2019 Jul 25;51:39-48
pubmed: 30790718
PLoS Comput Biol. 2019 Jun 17;15(6):e1006619
pubmed: 31206508
Diseases. 2018 Jun 29;6(3):
pubmed: 29966270
Front Chem. 2018 Mar 12;6:57
pubmed: 29594101
J Immunother Cancer. 2017 Nov 21;5(1):94
pubmed: 29157296
Open Heart. 2019 Apr 23;6(1):e000993
pubmed: 31168383
Curr Urol Rep. 2019 Nov 28;20(12):84
pubmed: 31781942
Eur Urol Focus. 2018 Jul;4(4):522-524
pubmed: 30197040
Cell Prolif. 2019 Nov;52(6):e12659
pubmed: 31469460
Nat Rev Urol. 2018 Dec;15(12):735-749
pubmed: 30315209
Gut. 2016 Feb;65(2):330-9
pubmed: 26338727
J Pathol. 2019 Oct;249(2):151-165
pubmed: 31102277
Cancers (Basel). 2020 Jan 30;12(2):
pubmed: 32019056
Front Oncol. 2019 Mar 01;9:121
pubmed: 30881921
Oncotarget. 2016 Jul 19;7(29):45479-45488
pubmed: 27323781
J Urol. 2013 Oct;190(4):1192-9
pubmed: 23648222
Eur Urol Focus. 2016 Apr;2(1):67-76
pubmed: 28723453
Expert Opin Pharmacother. 2019 Feb;20(2):201-208
pubmed: 30412003
J Transl Med. 2019 Oct 7;17(1):337
pubmed: 31590671
Adv Immunol. 2006;90:297-339
pubmed: 16730267
Biomed Res Int. 2018 Oct 3;2018:9836256
pubmed: 30402498
Front Immunol. 2019 Jun 26;10:1460
pubmed: 31297119
Urology. 2019 Apr;126:10-15
pubmed: 30615894
FEMS Microbiol Lett. 2010 May;306(2):103-9
pubmed: 20529131
Urol Clin North Am. 2020 Feb;47(1):35-46
pubmed: 31757298
World J Urol. 2019 Jan;37(1):15-29
pubmed: 30547196
Indian J Urol. 2018 Jan-Mar;34(1):11-19
pubmed: 29343907
Int J Biochem Cell Biol. 2015 Dec;69:121-31
pubmed: 26494003
Target Oncol. 2019 Jun;14(3):247-252
pubmed: 31073691